Tower Research Capital (TRC)’s Dogwood Therapeutics DWTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DWTX
Tower Research Capital (TRC)'s DWTX Position: Q3 2026 in Review
Tower Research Capital (TRC) increased its Dogwood Therapeutics (DWTX) stake by 127% in Q3 2026, buying an estimated $7.1K and bringing the position to 7,036 shares worth $9.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4363.
Tower Research Capital (TRC) first reported a position in DWTX in Q1 2021 and has held it in 19 quarters since. The position peaked at $17K in Q1 2026. 22 funds tracked by Wall St. Rank hold DWTX as of Q3 2026.
- Tower Research Capital (TRC) held 7,036 shares of Dogwood Therapeutics worth $9.5K as of Q3 2026.
- Tower Research Capital (TRC) bought 3,943 Dogwood Therapeutics shares in Q3 2026, an estimated $7.1K.
- Dogwood Therapeutics made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #4363 holding.
- Tower Research Capital (TRC) first reported a position in Dogwood Therapeutics in Q1 2021 and has held it in 19 quarters since.
- Tower Research Capital (TRC)'s Dogwood Therapeutics position peaked at $17K in Q1 2026.
- 22 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.